Crossmark Global Holdings Inc. Grows Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Crossmark Global Holdings Inc. raised its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 11.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,064 shares of the biotechnology company’s stock after buying an additional 422 shares during the quarter. Crossmark Global Holdings Inc.’s holdings in Axon Enterprise were worth $2,415,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. Quent Capital LLC increased its position in Axon Enterprise by 1,875.0% during the third quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock valued at $32,000 after acquiring an additional 75 shares during the last quarter. Prestige Wealth Management Group LLC boosted its position in shares of Axon Enterprise by 115.8% during the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock valued at $33,000 after acquiring an additional 44 shares during the last quarter. Brooklyn Investment Group purchased a new position in Axon Enterprise in the third quarter worth about $41,000. Planning Capital Management Corp boosted its stake in Axon Enterprise by 83.3% during the third quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after buying an additional 55 shares during the period. Finally, Friedenthal Financial purchased a new position in shares of Axon Enterprise during the third quarter valued at approximately $51,000. 79.08% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

AXON has been the topic of several research analyst reports. TD Cowen assumed coverage on Axon Enterprise in a research note on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price objective on the stock. Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and lifted their price objective for the company from $500.00 to $700.00 in a research note on Tuesday, December 3rd. JMP Securities raised their price objective on shares of Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a research note on Thursday, October 31st. The Goldman Sachs Group increased their target price on Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a research report on Wednesday, October 23rd. Finally, Northland Securities lifted their target price on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research note on Monday, November 11th. One analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $504.92.

Insider Activity at Axon Enterprise

In other news, insider Jeffrey C. Kunins sold 21,834 shares of the business’s stock in a transaction dated Tuesday, November 12th. The stock was sold at an average price of $593.88, for a total value of $12,966,775.92. Following the completion of the sale, the insider now directly owns 154,394 shares of the company’s stock, valued at approximately $91,691,508.72. The trade was a 12.39 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Julie A. Cullivan sold 1,261 shares of the stock in a transaction that occurred on Wednesday, December 4th. The shares were sold at an average price of $682.06, for a total value of $860,077.66. Following the completion of the sale, the director now directly owns 2,392 shares of the company’s stock, valued at $1,631,487.52. The trade was a 34.52 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 50,545 shares of company stock worth $30,721,337. Corporate insiders own 6.10% of the company’s stock.

Axon Enterprise Trading Up 1.0 %

AXON opened at $613.38 on Friday. The firm has a market cap of $46.77 billion, a P/E ratio of 158.50, a P/E/G ratio of 6.07 and a beta of 1.04. Axon Enterprise, Inc. has a 52 week low of $247.04 and a 52 week high of $698.67. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The business has a fifty day simple moving average of $617.43 and a 200-day simple moving average of $467.42.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.